semaglutide type 1 diabetes randomized trial 2024 SELECT Trial: Cuts Major CVD Risk by 20% in Overweight/Obese Adults Without Efficacy and Safety of Once-Weekly
Pay in 4 interest-free payments of $5.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


01438-2/asset/9233ac5a-285a-4906-ac5e-508f04e62412/main.assets/gr1_lrg.jpg)


















01751-7/asset/6309d074-38cb-40bc-984b-962ca1dbd6df/main.assets/gr2b_lrg.jpg)

![PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/5-Table1-1.png)





